There is a need to investigate processes that enable sludge re-use while enhancing sewage treatment efficiency. Mechanically disintegrated thickened surplus activated sludge (SAS) and fermented primary sludge were compared for their capacity to produce a carbon source suitable for BNR by completing nutrient removal predictive tests. Mechanically disintegration of SAS using a deflaker enhanced volatile fatty acids (VFAs) content from 92 to 374 mg l(-1) (4.1-fold increase). In comparison, primary sludge fermentation increased the VFAs content from 3.5 g l(-1) to a final concentration of 8.7 g l(-1) (2.5-fold increase). The carbon source obtained from disintegration and fermentation treatments improved phosphate (PO(4)-P) release and denitrification by up to 0.04 mg NO(3)-Ng(-1)VSS min(-1) and 0.031 mg PO(4)-Pg(-1)VSS min(-1), respectively, in comparison to acetate (0.023 mg NO(3)-Ng(-1)VSS min(-1)and 0.010 mg PO(4)-Pg(-1)VSS min(-1)). Overall, both types of sludge were suitable for BNR but disintegrated SAS displayed lower carbon to nutrient ratios of 8 for SCOD:PO(4)-P and 9 for SCOD:NO(3)-N. On the other hand, SAS increased the concentration of PO(4)-P in the settled sewage by a further 0.97 g PO(4)-P kg(-1)SCOD indicating its potential negative impact towards nutrient recycling in the BNR process.
Thyroid carcinoma is the most common endocrine malignancy in dogs. Thyroidectomy and radiation therapy control local disease, yet are not always feasible, and efficacious medical therapies need to be identified. Toceranib phosphate has been reported to provide clinical benefit (CB) in dogs with thyroid carcinoma, while its role in treatment-naïve thyroid tumours has not been well-described. The objective of this study was to describe the use of toceranib in the management of thyroid carcinomas in dogs in both the naïve-disease and prior therapy-settings. A medical record search identified 42 dogs diagnosed with thyroid carcinoma and treated with toceranib, of which 26 and 16 dogs were in settings of naïve-disease and after prior therapy, respectively. Twenty-three (88.4%) and twelve (75%) dogs experienced CB in the naïve and prior therapy settings, respectively. The median [95% confidence interval] progression free interval (PFI) for dogs in the naïve and prior therapy settings were 206 [106,740] and 1015 [92,1015] days, respectively. The median overall survival time (OST) for dogs in the naïve and prior therapy settings were 563 [246,916] and 1082 [289,1894] days, respectively. Overall, the data provided no evidence for differences in overall PFI (P > .20) or OST (P = .15) between settings. However, when asymptomatic at the time of diagnosis, dogs in the naïve setting showed poorer survival prognosis (estimated hazard ratio 17.2 [1.8, 163]) relative to dogs in the prior therapy setting. This study characterizes PFI, OST and CB with minimal AE in dogs with thyroid carcinoma treated with toceranib in both the naïve and prior therapy settings.
The ability of selected bacteria: Myxococcus xanthus, Bacillus pumilus, Halobacterium salinarum, and Brevibacterium antiquum to produce phosphorus bio‐mineral in settled wastewater and sludge dewatering centrifuge liquors was investigated. B. pumilus and B. antiquum were capable of growing and producing bio‐minerals identified as struvite that reached up to 250 µm in size within ten days. This study opens a completely new route to remove and recover phosphorus as struvite from wastewater, with advantages such as being able to use streams with variable phosphorus concentrations of (7–30 mg/L) and no need for external chemicals.
It is proposed that anaerobic treatment of municipal wastewater in temperate climates is attainable through the fortification of wastewater with primary sewage sludge to enhance the chemical oxygen demand (COD). Three bench-scale up-flow anaerobic sludge blanket (UASB) bioreactors (0.5 L) were operated to provide a preliminary verification of this approach. Mass and energy balances were modelled using the GPS-X (COST model, population equivalent of 118,500) to determine the energy balance of the primary sludge wastewater fortification process flowsheet in comparison with conventional aerobic secondary treatment with activated sludge. The addition of 5% primary sludge by volume to crude wastewater pretreated with ultrasound resulted in an increase in total COD from 536 mg L(-1) to 2300 mg L(-1). A COD removal of 86% +/- 8% and methane production of 400 mL L(-1) d(-1) were achieved in the reactor that was supplied with this primary sludge fortified wastewater. In comparison a COD reduction of 77% +/- 8% and 40 mL L(-1) d(-1) of methane were observed in the reactor which was supplied with crude wastewater only, and a 79% +/- 8% COD removal and 156 mL L(-1) d(-1) of methane were observed in UASB2, which was supplied with crude wastewater pretreated with ultrasound. The modelled energy balance for the fortified wastewater treatment process flowsheet was -305 kWh d(-1) compared with -937 kWh d(-1) in the aerobic flowsheet, corresponding to an energy saving of 67%.
The current standard method used for measuring soluble phosphate in environmental water samples is based on a colourimetric approach, developed in the early 1960s. In order to provide an alternative, label free sensing solution, a molecularly imprinted polymer (MIP) was designed to function as a phosphate receptor. A combination of functional monomer (N-allylthiourea), cross-linker and monomer/template ratios were optimised in order to maximise the binding capacity for phosphate. When produced in membrane format, the MIP's ability to produce a reversible change in conductance in the presence of phosphate was explored for fabrication of a sensor which was able to selectively detect the presence of phosphate compared to sulphate, nitrate and chloride. In wastewater samples the sensor had a limit of detection of 0.16 mg P/l, and a linear range between 0.66 and 8 mg P/l. This is below the minimum monitoring level (1 mg P/l) as required by current legislation for wastewater discharges, making the sensor as developed promising for direct quantification of phosphate in environmental monitoring applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.